Find Your Funding Opportunity

Forecast to Publish a Funding Opportunity Announcement for Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
Bookmarked grants will display in your Account Setting page

Service Source Final Application Due Date Funding Available Match Required
Health Care Federal
HHS
11-21-2025 N/A No Match
Required
  • Service
  • Source
  • Final Application Due Date
  • Funding Available
  • Match Required
Status
  • Past
  • Current
  • Forecasted
    • Opportunity Type Discretionary
    • CFDA

      93.393 -- Cancer Cause and Prevention Research

      93.394 -- Cancer Detection and Diagnosis Research

      93.395 -- Cancer Treatment Research

      93.396 -- Cancer Biology Research

      93.399 -- Cancer Control

    Description

    The National Cancer Institute intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI'sInformatics Technology for Cancer Research(ITCR) Program, this NOFO will focus on early-stage development from prototyping to initial dissemination. Early-stage development is defined for the purpose of this NOFO as initial tool development or the significant modification of existing tools for new applications. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, proposed development plans must have a clear rationale for why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from driving research projects and other usersthroughout the development process must be included.

    This NOFO will encourage applications that involve the development of new, user-friendly informatics technologies that support a wide range of cancer research, including discovery biology, population studies, as well as clinical and translational research. The emphasis will be on uniqueness and potential impact on cancer research. In addition, all projects proposed in response to this NOFO must involve the following general attributes:

    • Potential to advance driving cancer research projects and the cancer research field in general
    • Novel informatics capabilities for the targeted cancer research domain
    • Compelling plans and processes for engaging end users to evaluate and apply the tool or resource
    • A realistic timeline and milestones for technology development

    Applications are not being solicited at this time. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.This NOFO will utilize the U01 activity code. Investigators with expertise and insights intocancer informatics are encouraged to begin to consider applying for this NOFO.

    Eligibility
    • IHE
    • Local Government
    • Non-Profit
    • Other
    • State Government
    • Tribal Government
    Key Date(s)
    • July 02, 2025: Last Updated Date
    • July 02, 2025: Forecasted Date
    • August 29, 2025: Estimated Post Date
    • November 21, 2025: Estimated Application Due Date
    • July 01, 2026: Estimated Project Start Date
    • July 01, 2026: Estimated Award Date
    Contact Information
    Juli Klemm, PhD National Cancer Institute 202-853-7889 juli.klemm@nih.gov

    DROP US A LINE

    Feedback Feedback

    Your opinion is important to us

    • How would you rate your overall experience on our website?

    • How easy is it to find the information you need?

    • How do you rate the look & feel of our website?

    • How could we improve our website?